Welcome to my home page. I am an adjunct Research Fellow in Pharmacometrics at the Australian Centre for Pharmacometrics, UniSA Clinical and Health Sciences.
My research interest is in using innovative modelling and simulation approaches to aid optimal drug development, precision drug use, and regulatory decisions. I use newly available clinical trial data to develop clinical prediction tools or applications that provide personalised likelihoods of expected therapeutic and adverse outcomes to contemporary rheumatoid arthritis and cancer medicines. Such tools allow informed treatment decisions to be made based on patient’s characteristics which may be predictive of efficacy or toxicity.
I completed a BSc in Pharmacy at University of ... Read more
About me
Welcome to my home page. I am an adjunct Research Fellow in Pharmacometrics at the Australian Centre for Pharmacometrics, UniSA Clinical and Health Sciences.
My research interest is in using innovative modelling and simulation approaches to aid optimal drug development, precision drug use, and regulatory decisions. I use newly available clinical trial data to develop clinical prediction tools or applications that provide personalised likelihoods of expected therapeutic and adverse outcomes to contemporary rheumatoid arthritis and cancer medicines. Such tools allow informed treatment decisions to be made based on patient’s characteristics which may be predictive of efficacy or toxicity.
I completed a BSc in Pharmacy at University of Jordan in 2009, an MSc in Pharmaceutical Sciences at the University of Iowa, USA in 2011, and a PhD in Pharmacometrics at University of South Australia in 2017.
Our research group is always interested in identifying and working with PhD and Honours students, and have several projects available. Students would need to obtain a scholarship that will cover their own living expenses and tuition fees, but we are more than happy to support qualified students in applying for available funding. Please contact me if you are interested.
Research
Excludes commercial-in-confidence projects.
Model based methods to predict clinical drug exposure from formulation characteristics, Mayne Pharma Pty Ltd, 10/07/2017 - 09/07/2020
Development of Pharmacometric Models of the Drug Itraconazole, Mayne Pharma Pty Ltd, 29/01/2016 - 30/09/2016
Model based methods to predict clinical drug exposure from formulation characteristics, CSIRO SIEF STEM+Business fellowship, Australia, 08/2017 - 07/2020
Development of pharmacometric models of the drug itraconazole, Mayne Pharma Pty Ltd, Australia, 02/2016 - 06/2017
Transdermal drug delivery of the drug letrozole, Qatar University, Qatar, 02/2012 - 02/2014
Investigation of the effect of Drug-HPMC interaction on in vitro drug release, Abbott Laboratories, USA, 05/2010 - 08/2010
Development and characterization of floating and sustained release formulations using polymer-based drug delivery. The University of Jordan, Jordan, 02/2009 - 06/2009
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2018 |
Open access
4
4
|
| 2016 |
63
71
3
|
| 2016 |
52
21
1
|
| 2015 |
Open access
5
5
|
| 2015 |
Open access
55
49
12
|
| Year | Output |
|---|---|
| 2023 |
Open access
|
| 2023 |
Open access
|
| 2022 |
3
3
3
|
| 2022 |
Open access
1
7
|
| 2022 |
Open access
2
2
|
| 2022 |
Open access
|
| 2022 |
Open access
|
| 2022 |
Open access
|
| 2022 |
Open access
1
|
| 2021 |
Open access
9
8
3
|
| 2021 |
Open access
|
| 2021 |
Open access
13
10
4
|
| 2021 |
Open access
11
9
4
|
| 2021 |
Open access
4
2
3
|
| 2020 |
Open access
9
12
1
|
| 2020 |
Open access
14
12
1
|
| 2019 |
Open access
8
8
1
|
| 2018 |
Open access
4
4
|
| 2017 |
132
116
11
|
| 2017 |
Open access
6
5
10
|
| 2016 |
63
71
3
|
| 2016 |
52
21
1
|
| 2016 |
24
21
14
|
| 2016 |
Open access
22
20
1
|
| 2015 |
Open access
5
5
|
| 2015 |
Open access
55
49
12
|
| 2011 |
Open access
16
14
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Aalborg University | DENMARK |
| Flinders Medical Centre | AUSTRALIA |
| Flinders University | AUSTRALIA |
| George Institute for Global Health | AUSTRALIA |
| Harvard University | UNITED STATES |
| Indiana University | UNITED STATES |
| Jordan University of Science and Technology | JORDAN |
| Mayne Pharma Pty Ltd | AUSTRALIA |
| National Institute of Health Doctor Ricardo Jorge | PORTUGAL |
| National Institute of Health Dr. Ricardo Jorge | PORTUGAL |
| Prince of Songkla University | THAILAND |
| Royal Adelaide Hospital | AUSTRALIA |
| University of Adelaide | AUSTRALIA |
| University of Copenhagen | DENMARK |
| University of Jordan | JORDAN |
| University of New South Wales | AUSTRALIA |
| University of Otago | NEW ZEALAND |
| University of Sharjah | UNITED ARAB EMIRATES |
| University of South Australia | AUSTRALIA |
| University of Sydney | AUSTRALIA |
| University of Toledo | UNITED STATES |
| UNSW Sydney | AUSTRALIA |
| Western Sydney University | AUSTRALIA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
Local Organizing Committee18th Population Approach Group of Australia and New Zealand Meeting, Adelaide |
2017 |
MemberAmerican Association for Advancement of Science |
2017 |
MemberAmerican Association of Pharmaceutical Scientists |
2017 |
MemberJordan Pharmacists Association |
2017 |
MemberThe Population Approach Group of Australia and New Zealand |
2017 |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Development of ex vivo models to predict the efficacy of disease modifying agents in rheumatoid arthritis | Current |
| Development of drug-eluting stents for the localised delivery of 5-fluorouracil targeted towards the treatment of gastrointestinal cancers | Completed |
| Development of drug-eluting stents using dip-coating and 3D printing techniques for the localised treatment of oesophageal cancer | Completed |
